Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.

OBJECTIVE: To characterize the bioavailability and pharmacokinetics of oral and injectable formulations of methadone after IV, oral, and intragastric administration in horses. ANIMALS: 6 healthy adult horses. PROCEDURES: Horses received single doses (each 0.15 mg/kg) of an oral formulation of methadone hydrochloride orally or intragastrically or an injectable formulation of the drug orally, intragastrically, or IV (5 experimental treatments/horse; 2-week washout period between each experimental treatment). A blood sample was collected from each horse before and at predetermined time points over a 360-minute period after each administration of the drug to determine serum drug concentration by use of gas chromatography-mass spectrometry analysis and to estimate pharmacokinetic parameters by use of a noncompartmental model. Horses were monitored for adverse effects. RESULTS: In treated horses, serum methadone concentrations were equivalent to or higher than the effective concentration range reported for humans, without induction of adverse effects. Oral pharmacokinetics in horses included a short half-life (approx 1 hour), high total body clearance corrected for bioavailability (5 to 8 mL/min/kg), and small apparent volume of distribution corrected for bioavailability (0.6 to 0.9 L/kg). The bioavailability of methadone administered orally was approximately 3 times that associated with intragastric administration. CONCLUSIONS AND CLINICAL RELEVANCE: Absorption of methadone in the small intestine in horses appeared to be limited owing to the low bioavailability after intragastric administration. Better understanding of drug disposition, including absorption, could lead to a more appropriate choice of administration route that would enhance analgesia and minimize adverse effects in horses.

Behavioral training and hydraulic chute restraint enables handling of eland antelope (Taurotragus oryx) without general anesthesia.

Difficulties and risks associated with restraining large nondomestic ungulates are limiting factors toward developing and applying assisted reproductive technologies, such as artificial insemination and embryo transfer. In this study on 10 female eland (Taurotragus oryx), we evaluated the use of behavioral training and handling handling in a hydraulic chute to perform transvaginal ultrasound-guided oocyte retrieval and other clinical procedures. Nine females were conditioned to associate specific sound cues with food treats. The interval from the audio cue until acceptance of handheld treats varied among females (1.8-58.3 min). Animals also differed in their response to training for voluntary entry into the chute. Handling eland for oocyte retrieval in the hydraulic chute required xylazine sedation. During sedation and handling, eland undergoing oocyte retrieval procedures had higher blood glucose levels (14.4 +/- 3.1) than females handled similarly but without oocyte retrieval (9.3 +/- 2.7 mmol/L). Plasma osmotic pressure, hematocrit, and creatine phosphokinase activity were similar between these two groups. Females that were more difficult to train had higher blood glucose levels than the more cooperative animals. Cooperative females had fewer vertical stripes on their sides. More than 40 procedures were conducted without complications or mortality. The combination of behavioral conditioning-training and restraint of sedated eland in a hydraulic chute was a reliable and repeatable method for performing minimally invasive assisted reproductive techniques.